Women's Imaging

Pairing breast MRI with a test that characterizes breast cancer genes can lead to a more personalized treatment approach for patients with ductal carcinoma in situ (DCIS), reported authors of a recent study published in JAMA Oncology.

Stationary digital breast tomosynthesis (sDBT) improved radiologists’ accuracy in detecting malignancies and was favored over mammography, reported authors of a Jan. 16 study published in Academic Radiology.

Edward-Elmhurst Health is the first health system in the Chicagoland area to offer molecular breast imaging and comes just in time for Illinois' newly enacted breast density notification law, according to a report published Jan. 14 by Crain’s Chicago Business.

Kheiron Medical, an artificial intelligence (AI) medical imaging startup based in London, is the latest company to announce its research efforts in using AI to identify signs of breast cancer from mammograms and help alleviate the U.K.’s current radiologist shortage, according to a recent article by the Financial Times.

The Society of Breast Imaging (SBI) addressed the importance of diversity in breast imaging in a recent statement published online Jan. 9, stating that breast cancer does not affect all ethnic and socioeconomic populations equally.

Although many insurance providers have invested in price calculators for patients to determine out-of-pocket costs, one Philadelphia woman discovered they may severely underestimate actual prices for services, according to a recent report by The Philadelphia Inquirer.

Revamped guidelines on screening for breast cancer promote shared decision-making between women and their doctors. The new instructions were released by the Canadian Task Force on Preventative Health Care and published in the Canadian Medical Association Journal.

For women with certain breast cancer risk factors, annual mammograms beginning at age 30 may be beneficial, according to a large-scale study presented Wednesday, Nov. 28 at RSNA 2018.

“The new 2018 Digital Mammography QC Manual will promote uniformity and consistency of QC procedures across the broad spectrum of FDA approved manufacturers,” Eric Berns, PhD, manual author and chair of the ACR Subcommittee on Mammography Quality Assurance, said in a prepared statement.

“This technology can also be valuable to monitor high-risk patients who have increased risk of ovarian and breast cancers due to their genetic mutations,” Quing Zhu, PhD, and lead author of a recent Radiology study said.

Using ultrasound technology, researchers found simple ovarian cysts are not associated with an increased risk of ovarian cancer and do not require additional surveillance or surgical intervention, according to research published Nov. 12 in JAMA Internal Medicine.

Women who receive early and annual breast cancer screenings have lower mortality rates and benefit more from therapy at the time of diagnosis, according to new research published Nov. 8 in the journal Cancer.